Point72 Middle East FZE’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-29,344	Closed	-$30.8K	–	18
2023 Q4	$30.8K	Buy	29,344 +18,652	+174%	+$19.6K	﹤0.01%	790
2023 Q3	$73.2K	Buy	+10,692	New	+$73.2K	﹤0.01%	689
2023 Q1	–	Sell	-4,788	Closed	-$75.4K	–	1032
2022 Q4	$75.4K	Buy	+4,788	New	+$75.4K	﹤0.01%	824